Cart
sales@molnova.com
UCM-13207
CAS No. 1621536-10-4
UCM-13207( —— )
Catalog No. M37283 CAS No. 1621536-10-4
UCM-13207 is a specific ICMT inhibitor that improves progeria.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 250 | In Stock |
|
| 10MG | 358 | In Stock |
|
| 25MG | 561 | In Stock |
|
| 50MG | 737 | In Stock |
|
| 100MG | 986 | In Stock |
|
| 200MG | 1330 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUCM-13207
-
NoteResearch use only, not for human use.
-
Brief DescriptionUCM-13207 is a specific ICMT inhibitor that improves progeria.
-
DescriptionUCM-13207 (compound 21) is a selective ICMT inhibitor that ameliorates basic progeria-like features. UCM-13207 can improve the survival rate of LmnaG609G/G609G mice in the mouse premature aging model.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1621536-10-4
-
Formula Weight380.52
-
Molecular FormulaC24H32N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC=1C=CC=CC1)CCN(C(=O)C=2C=CC=CC2)CCCCCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Marcos-Ramiro B et al. Isoprenylcysteine carboxylmethyltransferase-based therapy for Hutchinson–Gilford progeria syndrome[J]. ACS Central Science, 2021, 7(8): 1300-1310.
molnova catalog
related products
-
Atrial natriuretic f...
Atrial Natriuretic Peptide (ANP) (1-28),rat (TFA) is the main circulating forms of Atrial Natriuretic Peptide (ANP) in rats, which strongly inhibit the secretion of Ang II - stimulated endothelin-1.
-
Bak - BH3
Bak - BH3
-
Kainic acid
In the CNS, Kainic acid is an effective agonist at excitatory amino acid receptor subtypes.
